Close
Help
Home Journals Subjects About My LA Reviewers Authors News Submit
.
(close)

(Ctrl-click to select multiple journals)


How should we address you?

Your email address


Enter the three character code
Visual CAPTCHA
Privacy Statement

Neuroscience & neurology

Get Updates

Neuroscience & neurology research articles, Neuroscience & neurology research article, Neuroscience & neurology journals, Neuroscience & neurology journal, Neuroscience & neurology articles, Research on Breast cancer, Neuroscience & neurology



Sign up for free journal updates
How should we address you?
Your email address
Enter the three character code
Visual CAPTCHA

peer reviewed open access journals 80




Latest news
  • Interview with Clinical Medicine Insights: Oncology editorial board member Prof. M. Wasif Saif
  • - 18/Jun/2010
  • Interview with Biomarkers in Cancer editorial board member Dr Xiaofeng Zhou
  • - 18/Jun/2010
  • Interview with Microbiology Insights editorial board member Dr Viroj Wiwanitkit
  • - 18/Jun/2010
  • Interview with Cell & Tissue Transplantation & Therapy editorial board member Dr Terje Forslund
  • - 17/Jun/2010
  • Interview with Nutrition and Metabolic Insights editorial board member Prof.Abdulaziz I.AL-Othaimeen
  • - 17/Jun/2010
  • Interview with Biomarker Insights editorial board member Dr Steven R. Myers
  • - 16/Jun/2010
  • Interview with Immunology and Immunogenetics Insights editorial board member Dr Robert Yarchoan
  • - 16/Jun/2010
  • Interview with International Journal of Tryptophan Research editorial board member Dr Martin Reuter
  • - 15/Jun/2010
  • Interview with Cancer Informatics editorial board member Dr Philip Crooke
  • - 15/Jun/2010
  • Interview with Environmental Health Insights editorial board member Dr Lalita Bharadwaj
  • - 15/Jun/2010
  • Interview with Integrative Medicine Insights editorial board member Dr Merrijoy Kelner
  • - 15/Jun/2010
  • Interview with Clinical Medicine Insights: Reproductive Health editorial board member Dr Lior Lowenstein
  • - 15/Jun/2010
  • Interview with Clinical Medicine Insights: Trauma and Intensive Medicine editorial board member Dr Michael Y. Wang
  • - 09/Jun/2010
  • Interview with Environmental Health Insights editorial board member Dr Lars Carlsen
  • - 09/Jun/2010
  • Interview with Evolutionary Bioinformatics editorial board member Dr Carsten Wiuf
  • - 04/Jun/2010
  • Interview with Translational Oncongenomics Editor in Chief Dr Michael Spinella
  • - 04/Jun/2010
  • Interview with Cancer Informatics editorial board member Dr Jimmy T. Efird
  • - 04/Jun/2010
  • Interview with Journal of Cell Death editorial board member Dr Hardy Kornfeld
  • - 04/Jun/2010
  • Interview with Journal of Cell Death editorial board member Dr Bruce S. Bochner
  • - 03/Jun/2010
  • Interview with Cancer Informatics editorial board member Dr Bradley J Erickson
  • - 03/Jun/2010
  • Biomarker Insights Editor in Chief co-author of Nature cover story
  • - 06/May/2010
  • Author interview with Dr Esther Uña Cidón
  • - 26/Apr/2010
  • Author interview with Dr Thomas Ostermann
  • - 24/Mar/2010
  • Author interview with Dr Yoshihito Yokoyama
  • - 11/Mar/2010

Latest pictures




Latest articles

Most read articles


(previous 30 days)Site updates
50
Articles published:
0
Comments:
23
Blog entries:
Get Updates
Get Updates
Abstract
Full-text PDF

Detection of Amide and Aromatic Proton Resonances of Human Brain Metabolites Using Localized Correlated Spectroscopy Combined with Two Different Water Suppression Schemes     (15/Jun/2010)


The purpose of the study was to demonstrate the J-coupling connectivity network between the amide, aliphatic, and aromatic proton resonances of metabolites in human brain using two-dimensional (2D) localized correlated spectroscopy (L-COSY). Two different global water suppression techniques were combined with L-COSY, one before and another after localizing the...


Abstract
Full-text PDF

Effectiveness and Safety of Rizatriptan Benzoate 10 mg in the Treatment of Migraine Headaches     (11/Jun/2010)


Background: Patients that do not achieve therapeutic response with over the counter non-triptan medications may benefit from triptan-based treatments. Objective: Phase IV, open-label, multi-center, prospective cohort study assessing the effectiveness of rizatriptan in the management of migraines for patients that have not responded to non-triptan treatment. Methods: Patients were treated with one...


Abstract
Full-text PDF

On the Biological Importance of the 3-hydroxyanthranilic Acid: Anthranilic Acid Ratio     (10/Jun/2010)


Of the major components of the kynurenine pathway for the oxidative metabolism of tryptophan, most attention has focussed on the N-methyl-D-aspartate (NMDA) receptor agonist quinolinic acid, and the glutamate receptor blocker kynurenic acid. However, there is increasing evidence that the redox-active compound 3-hydroxyanthranilic acid may also have potent actions on...


Abstract
Full-text PDF

Effects of Acute Tryptophan Depletion on Three Different Types of Behavioral Impulsivity     (10/Jun/2010)


Introduction: While central nervous system serotonin has been implicated in a variety of problematic impulsive behaviors, biological manipulation of brain serotonin using acute tryptophan depletion for studying changes in impulsive behavior has received little attention. Methods: Using identical treatment conditions, we examined the effects of reduced serotonin synthesis for each of...


Abstract
Full-text PDF

Tryptophan, Neurodegeneration and HIV-Associated Neurocognitive Disorder     (10/Jun/2010)


This review presents an up-to-date assessment of the role of the tryptophan metabolic and catabolic pathways in neurodegenerative disease and HIV-associated neurocognitive disorder. The kynurenine pathway and the effects of each of its enzymes and products are reviewed. The differential expression of the kynurenine pathway in cells within the brain,...


Abstract
Full-text PDF

Endogenous Kynurenine Aminotransferases Inhibitor is Proposed to Act as “Glia Depressing Factor” (GDF)     (11/May/2010)


The endogenous neuroinhibitory amino acid receptor antagonist kynurenic acid (KYNA) has been hypothetically linked to physiological processes and to the pathogenesis of several brain disorders. The aim of this study was to search KYNA metabolism i.e. KYNA levels and enzymes synthesising KYNA kynurenine aminotransferase I and II (KAT I and...


Abstract
Full-text PDF

Decreased Serum Cu/Zn SOD Associated with High Copper in Children with Attention Deficit Hyperactivity Disorder (ADHD)     (04/May/2010)


Aim: To assess serum Cu/Zn SOD (Superoxide Dismutase) concentration in children with ADHD and evaluate its possible relationship to Cu and Zn levels. Subjects and methods: Serum from 22 children with ADHD and 20 healthy control children without ADHD and 19 autistic children without ADHD were tested for Cu/Zn SOD using...


Abstract
Full-text PDF

Pharmacotherapy of Restless Legs Syndrome with Pramipexole     (28/Apr/2010)


Restless Legs Syndrome (RLS) is one of the most common neurological diseases characterized by an urge to move the legs, often associated with unpleasant sensations relieved by movement. It is engendered by rest, and is worse in the evening or at night. Patients affected by severe RLS should be treated pharmacologically....


Abstract
Full-text PDF

Detection of RNA in the Plasma of Patients with Sporadic Creutzfeldt–Jakob Disease, Gerstmann–Straüssler Syndrome and Other Non-Transmissible Spongiform Encephalopathy Brain Disorders     (14/Apr/2010)


The infectious agent of transmissible spongiform encephalopathy (TSE) was assumed to be the aggregate of abnormal prion protein isoform (PrPsc). We observed that lowering the pH of 3% SDS-inoculated plasma or brain homogenate after PK digestion to 4.5 (acidic SDS condition) enabled to precipitate proteinase K-resistant prion protein (PrPres) in...


Abstract
Full-text PDF

Zonisamide as Adjunctive Therapy for Adults with Partial-Onset Epileptic Seizures: An Efficacy and Safety Review     (08/Apr/2010)


Purpose: To provide a review of randomized controlled trials (RCTs) on the efficacy and safety of zonisamide as an adjunctive treatment for partial-onset seizures in epilepsy patients ages 12 years and above. Methods: Medline literature search for published double-blind RCTs involving zonisamide as adjunctive treatment for simple partial, complex...


Abstract
Full-text PDF

Emerging Therapies for the Management of Multiple Sclerosis     (07/Apr/2010)


Objective: To provide a comprehensive overview on the emerging treatments used for the treatment management of multiple sclerosis (MS). Data Sources: PubMed, MEDLINE, Cochrane, and Toxnet databases were used to conduct all comprehensive literature searches over the time period of 1989 to 2009. Search terms such as: multiple sclerosis and oral...


Abstract
Full-text PDF

Psychotropic Effects of Anticonvulsant Drugs in Patients with Epilepsy     (07/Apr/2010)


Anticonvulsant drugs continue to be the mainstay of epilepsy treatment but benefits of seizure control need to be balanced with the psychotropic potential of this class of compounds. The present paper is aimed at discussing positive and negative effects of anticonvulsant drugs on mood in patients with epilepsy. In general...


Abstract
Full-text PDF

“Old” and Emerging Therapies of Human Tremor     (25/Mar/2010)


Tremor is the most common movement disorder encountered during daily practice. Most forms of tremor are currently managed with drugs. However, the response of tremor to pharmacotherapy is variable and a combination of agents is often required. Surgery is considered when the response is not sufficient. In particular deep brain...


Abstract
Full-text PDF

The Impact of COMT-inhibition on Gastrointestinal Levodopa Absorption in Patients with Parkinson’s Disease     (17/Mar/2010)


The drug Levodopa (LD) is an efficient compound for the treatment of patients with Parkinson’s disease (PD). Its short half life generates plasma behaviour of LD with peaks and troughs. Therefore, following the LD transport into the brain and the conversion to dopamine, an alternating stimulation of nigrostriatal postsynaptic dopamine...


Article: Juvenile Bow Hunter’s Stroke without Hemodynamic Changes
Full-text PDFAbstract

Juvenile Bow Hunter’s Stroke without Hemodynamic Changes     (16/Mar/2010)


Bow hunter’s stroke (BHS) is a cerebrovascular disease caused by occlusion of the vertebral artery (VA) on head rotation. BHS is generally associated with hemodynamic changes, often leading to vertebrobasilar insufficiency symptoms, such as vertigo and faintness. Although artery-to-artery embolism has also been proposed as an underlying mechanism, it remains controversial. This report documents a case of BHS without hemodynamic changes. We describe a 26-year-old male patient who had VA occlusion on head rotation and...


Abstract
Full-text PDF

Gender Ratios in Autism, Asperger Syndrome and Autism Spectrum Disorder     (05/Mar/2010)


Skewed sex ratios indicative of a greater preponderance of males over females (approximating 4:1) has perhaps been the most constant collective finding in autism spectrum conditions. More recent investigations have indicated a potential change to traditional estimates of gender ratios. We undertook analysis to calculate contemporaneous gender ratios based on...


Abstract
Pay-per-view

Lamotrigine: Once Daily Add-on Therapy for Epilepsy in Adults Experiencing Partial Onset Seizures     (02/Mar/2010)


Lamotrigine (LTG) is a newer antiepileptic medication that has multiple indications for epilepsy including add-on therapy for partial onset epilepsy in adults. The primary antiseizure mechanism of action is blockage of voltage-sensitive sodium channels which stabilizes neuronal membranes and inhibits excitatory presynaptic neurotransmitter release. It has linear pharmacokinetics with rapid...


Abstract
Full-text PDF

Role of the NMDA-receptor in Prepulse Inhibition in the Rat     (12/Feb/2010)


Kynurenic acid (KYNA) is an endogenous metabolite of tryptophan. Studies have revealed increased brain KYNA levels in patients with schizophrenia. Prepulse inhibition (PPI) is a behavioral model for sensorimotor gating and found to be reduced in schizophrenia. Previous studies have shown that pharmacologically elevated brain KYNA levels disrupt PPI in...


Abstract
Full-text PDF

Nursing Roles within a Stroke Telemedicine Network     (11/Feb/2010)


Time sensitive acute stroke treatments and the growing shortage of vascular neurologists compound to create a gap in the delivery of care to meet the American Stroke Association guidelines in underserviced regions. Audio/video consultation (telemedicine), which has been evolving since the late 1990’s, is a putative solution. While telemedicine can...


Abstract
Full-text PDF

Pharmacotherapy of Narcolepsy: Focus on Sodium Oxybate     (11/Feb/2010)


Narcolepsy is a complex disease with multiple symptoms that include excessive daytime sleepiness, cataplexy, hypnagogic hallucinations, and sleep paralysis. Pharmacologic management of patients with narcolepsy is based on treating these symptoms. Sodium oxybate, a neurotransmitter product of γ-amino butyric acid (GABA), is a Schedule III controlled substance in the US,...


Abstract
Full-text PDF

Pharmacotherapy of Seizures Associated with Lennox-Gastaut Syndrome     (10/Feb/2010)


Lennox-Gastaut syndrome is an epileptic encephalopathy starting in early childhood consisting of the triad of cognitive impairment, multiple seizures types and slow spike-wave complexes in the electroencephalogram. Global developmental delay is usually evident before the onset in patients with symptomatic LGS whereas children with cryptogenic LGS might have a normal...


Abstract
Full-text PDF

Quetiapine Induced Acute Dystonia in a Patient with History of Severe Head Injury     (03/Feb/2010)


A patient with a history of severe head injury 10 years ago regained ability to walk after years of being bound to a wheelchair. During the last psychiatric hospitalization, quetiapine was increased to therapeutic dose using a normal titration. As a result the patient developed dystonia of multiple muscle groups...


Abstract
Full-text PDF

Local Cell Proliferation Upon Enucleation in Direct Retinal Brain Targets in the Visual System of the Adult Mouse     (03/Feb/2010)


In this study we used incorporation of the DNA synthesis marker 5-bromo-2’-deoxyuridine or BrdU to visualize cell proliferation in the visual system of the adult mouse as a response to monocular enucleation. We detected new BrdU-labeled cells in different subcortical retinal target regions and we established a specific time frame...


Abstract
Full-text PDF

Bevacizumab: Review of Development, Pharmacology, and Application to Brain Tumors     (10/Nov/2009)


Bevacizumab is a humanised monoclonal antibody targeted to the vascular endothelial growth factor (VEGF). VEGF is the ligand for VEGF receptors (VEGFR), which are important for the development and maintenance of the angiogenic phenotype in high-grade solid tumors, including malignant gliomas. An overview of angiogenesis, VEGF, VEGFR, and the pharmacology...


Abstract
Full-text PDF

Pharmacotherapy of Major Depressive Disorder: Focus  on Duloxetine     (28/Oct/2009)


The serotonin-noradrenaline reuptake inhibitor duloxetine is a second-generation antidepressant for the treatment of major depressive disorder (MDD). Its inhibitory potency for serotonin (5-HT) and noradrenaline (NA) reuptake has been demonstrated in animal and in vitro studies. Human studies of peripheral markers of neurotransmission show inhibition of 5-HT reuptake by duloxetine...


Abstract
Full-text PDF

A Case of Fahr’s Disease Presenting as Chorea Successfully Treated by the Use of Quetiapine     (22/Oct/2009)


We report a case of 30-year-old man presenting chorea in his legs. A brain computed tomography (CT) scan showed bilateral symmetric calcifications in the basal ganglia, thalamus, cerebellum and subcortical white matter. Laboratory studies showed no abnormalities of serum calcium, phosphate, PTH, lactic acid, pyruvic acid and cerebrospinal fluid. Under...


Abstract
Full-text PDF

Dysfunction of Corticomotoneurons in Guillain-Barré Syndrome (GBS)?     (01/Oct/2009)


Guillain-Barré syndrome (GBS) is characterized by acute and symmetric flaccid paraparesis and areflexia. Involvement of the central nervous system has been infrequently reported. In the current issue of Clinical Medicine: Case reports, an unusual case of GBS with asymmetric muscle weakness was reported. Corticomotoneuronal dysfunction was invoked as a possible...


Abstract
Full-text PDF

Metabolic Complications of Bypass Surgery for Morbid Obesity     (18/Sep/2009)


Postoperative complications resulting from bariatric surgery can lead to severe vitamin-deficiency states. A patient who underwent bariatric bypass surgery and later developed Wernicke’s encephalopathy prompted us to present her interesting case history for discussion. Although bariatric surgery is known to be a risk factor for Wernicke’s encephalopathy, this diagnosis is...


Abstract
Full-text PDF

Anatomical and Functional Organization of Inhibitory Circuits in the Songbird Auditory Forebrain     (16/Sep/2009)


Recent studies on the anatomical and functional organization of GABAergic networks in central auditory circuits of the zebra finch have highlighted the strong impact of inhibitory mechanisms on both the central encoding and processing of acoustic information in a vocal learning species. Most of this work has focused on the...


Abstract
Full-text PDF

Ropinirole in the Treatment of Restless Legs Syndrome     (09/Sep/2009)


Restless Legs Syndrome (RLS) is a neurological disorder characterized by unpleasant sensations in the legs and an irresistible urge to move them to relieve discomfort. Evidence-based guidelines consider dopaminergic therapy to be the mainstay of treatment for RLS. Ropinirole is a modern, non-ergoline dopamine agonist which has been widely studied...